| Active substance |
Fluoxetine |
| Also known as |
Prozac |
| Blood pressure |
Typically has minimal effect on blood pressure |
| Chemical name |
(RS)-N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine |
| Dosage (medical) |
Typically 20 mg per day, may be adjusted based on response and tolerability |
| Dosage (sports) |
Not applicable as it is not used to enhance athletic performance |
| Effects |
Antidepressant, improves mood, sleep, appetite, and energy level |
| Formula |
C17H18F3NO |
| Half-life |
1 to 3 days for fluoxetine and 4 to 6 days for its active metabolite, norfluoxetine |
| Hepatotoxicity |
Low risk, but liver function tests are recommended during prolonged use |
| Lab Test |
Monitoring plasma levels is not routinely required but can be done if overdose is suspected or for pharmacokinetic studies |
| Main action |
Inhibits the reuptake of serotonin in the brain |
| Side effects |
Nausea, headache, dizziness, dry mouth, sweating, sleep disturbances, sexual dysfunction |
| Storage conditions |
Store at room temperature, away from moisture and heat |
| Strength |
20 mg |
| Substance class |
Selective Serotonin Reuptake Inhibitor (SSRI) |
| Trade name |
Prozac, Sarafem, among others |
| Use in sports |
None, as it does not enhance athletic performance |
| Water Retention |
Minimal |
| Manufacturer |
Intas Pharmaceuticals Ltd. |
| Packing |
10 caps/blister |
